Fjarde Ap-fonden’s Hologic HOLX Stock Holding History

Fjarde Ap-fonden’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-101,614	Closed	-$7.57M	–	540
2025 Q4	$7.57M	Buy	101,614 +11,100	+12%	+$811K	0.06%	266
2025 Q3	$6.11M	Sell	90,514 -9,400	-9%	-$624K	0.05%	294
2025 Q2	$6.51M	Buy	99,914 +47,700	+91%	+$2.86M	0.06%	282
2025 Q1	$3.23M	Buy	52,214 +8,826	+20%	+$585K	0.04%	376
2024 Q4	$3.13M	Sell	43,388 -41,000	-49%	-$3.2M	0.03%	420
2024 Q3	$6.87M	Buy	+84,388	New	+$6.75M	0.07%	275
2024 Q1	$5.56M	Buy	71,288 +19,600	+38%	+$1.46M	0.06%	320
2023 Q4	$3.69M	Buy	51,688 +5,600	+12%	+$390K	0.05%	400
2023 Q3	$3.2M	Sell	46,088 -8,000	-15%	-$605K	0.04%	417
2023 Q2	$4.38M	Sell	54,088 -6,992	-11%	-$571K	0.05%	349
2023 Q1	$4.93M	Sell	61,080 -8,400	-12%	-$676K	0.07%	309
2022 Q4	$5.2M	Buy	69,480 +17,692	+34%	+$1.26M	0.07%	293
2022 Q3	$3.59M	Hold	51,788	–	–	0.05%	405
2022 Q2	$3.59M	Sell	51,788 -15,400	-23%	-$1.14M	0.05%	405
2022 Q1	$5.16M	Sell	67,188 -3,741	-5%	-$269K	0.05%	381
2021 Q4	$5.43M	Buy	70,929 +2,900	+4%	+$213K	0.05%	383
2021 Q3	$5.02M	Sell	68,029 -600	-0.9%	-$45K	0.05%	394
2021 Q2	$4.58M	Sell	68,629 -5,300	-7%	-$354K	0.04%	438
2021 Q1	$5.5M	Sell	73,929 -4,000	-5%	-$304K	0.05%	380
2020 Q4	$5.68M	Sell	77,929 -9,500	-11%	-$671K	0.05%	342
2020 Q3	$5.81M	Sell	87,429 -6,900	-7%	-$437K	0.06%	291
2020 Q2	$5.38M	Buy	94,329 +4,060	+4%	+$199K	0.07%	289
2020 Q1	$3.17M	Sell	90,269 -12,700	-12%	-$605K	0.05%	368
2019 Q4	$5.38M	Buy	102,969 +4,600	+5%	+$229K	0.07%	311
2019 Q3	$4.97M	Sell	98,369 -4,117	-4%	-$203K	0.06%	315
2019 Q2	$4.92M	Buy	102,486 +900	+0.9%	+$41.6K	0.06%	340
2019 Q1	$4.92M	Buy	101,586 +28,172	+38%	+$1.27M	0.06%	324
2018 Q4	$3.02M	Sell	73,414 -7,300	-9%	-$299K	0.05%	370
2018 Q3	$3.31M	Sell	80,714 -805	-1%	-$32.5K	0.05%	433
2018 Q2	$3.24M	Buy	81,519 +2,710	+3%	+$104K	0.05%	441
2018 Q1	$2.94M	Buy	78,809 +1,004	+1%	+$40.6K	0.05%	471
2017 Q4	$3.33M	Buy	77,805 +11,186	+17%	+$446K	0.05%	433
2017 Q3	$2.44M	Buy	66,619 +14	+0%	+$565	0.05%	460
2017 Q2	$3.02M	Buy	66,605 +16,221	+32%	+$716K	0.06%	363
2017 Q1	$2.14M	Sell	50,384 -2,486	-5%	-$101K	0.05%	437
2016 Q4	$2.12M	Sell	52,870 -8,028	-13%	-$310K	0.05%	454
2016 Q3	$2.37M	Sell	60,898 -140	-0.2%	-$5.29K	0.05%	429
2016 Q2	$2.11M	Sell	61,038 -12,395	-17%	-$429K	0.05%	458
2016 Q1	$2.53M	Buy	73,433 +6,811	+10%	+$238K	0.06%	381
2015 Q4	$2.58M	Buy	66,622 +1,146	+2%	+$44.6K	0.07%	335
2015 Q3	$2.56M	Sell	65,476 -1,400	-2%	-$55.5K	0.07%	329
2015 Q2	$2.54M	Buy	66,876 +1,207	+2%	+$42.2K	0.06%	372
2015 Q1	$2.17M	Sell	65,669 -4,300	-6%	-$132K	0.05%	465
2014 Q4	$1.87M	Hold	69,969	–	–	0.04%	522
2014 Q3	$1.7M	Sell	69,969 -5,125	-7%	-$129K	0.04%	530
2014 Q2	$1.9M	Sell	75,094 -12,503	-14%	-$292K	0.04%	534
2014 Q1	$1.88M	Hold	87,597	–	–	0.04%	532
2013 Q4	$1.96M	Sell	87,597 -12,609	-13%	-$278K	0.04%	521
2013 Q3	$2.07M	Hold	100,206	–	–	0.04%	498
2013 Q2	$1.93M	Buy	+100,206	New	+$2.09M	0.04%	507

Other funds holding HOLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Fjarde Ap-fonden's HOLX Position: Q1 2026 in Review

Fjarde Ap-fonden sold out of Hologic (HOLX) in Q1 2026, closing a stake of 101,614 shares — an estimated $7.57M sold.

Fjarde Ap-fonden first reported a position in HOLX in Q2 2013 and held it in 50 quarters. The position peaked at $7.57M in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

Fjarde Ap-fonden reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
Fjarde Ap-fonden sold 101,614 Hologic shares in Q1 2026, an estimated $7.57M.
Fjarde Ap-fonden first reported a position in Hologic in Q2 2013 and held it in 50 quarters.
Fjarde Ap-fonden's Hologic position peaked at $7.57M in Q4 2025.
704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Fjarde Ap-fonden's 13F filing for Q1 2026, filed 27 Apr 2026.